NCT02908178View on ClinicalTrials.gov

Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ

CompletedOBSERVATIONAL
Enrollment

28,291

Participants

Timeline

Start Date

January 25, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

June 29, 2018

Conditions
Ductal Carcinoma In Situ
Interventions
PROCEDURE

Sentinel lymph node biopsy (SLNB)

Intervention is defined as that the DCIS patient has undergone SLNB. Patients in each cohort (group) include those who underwent SLNB (intervention) and those who did not (control).

Trial Locations (1)

20892

SEER-Medicare Dataset, Bethesda

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Yale University

OTHER

NCT02908178 - Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ | Biotech Hunter | Biotech Hunter